Resilience US, Inc. Capacity Update February 2024: Large Molecule

Founded in 2020, Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. With a strong network of sites across six states and one in Canada, Resilience provides innovative solutions and services for established and emerging therapies. Hear Evan Pasenello, Business Head of Biologics & Vaccines, discuss how Resilience can support your development and manufacturing programs.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma